EXEL EXELIXIS, INC.

NEUTRAL Impact: 3/10 Insider Cluster (2 insiders)
Horizon days Filed May 28, 2026 Processed 12d 8h ago
Insider cluster: 2 insiders, $3.8M total
Latest settled — T+5d ⚠ clustered
EXEL ▲ +4.71% at T+5d
NEUTRAL call ✓ call won +4.71% · α vs SPY +7.23% · entry $50.32 → $52.69
Next anchor: T+20d in 16d
Last close $51.74 (close Jun 8) · +2.83% from $50.32 entry
Entry anchored
May 28, 2026
via day open
T+1d
-0.24%
call -0.24% · α -0.50%
$50.20
settled 12d ago
T+5d
+4.71%
call +4.71% · α +7.23%
$52.69
settled 6d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Two EVPs at Exelixis sold a combined $3.79M in open-market sales over a one-week window. The sales total ~0.03% of the $12.6B market cap, well below the 0.1% threshold for materiality, and the cluster is composed entirely of C-suite sells, which per the literature are weak predictors of future returns. The historical calibration for this filing type shows a negative net alpha at T+20, and the score calibration indicates low observed win rates at scores 6-8, further tempering any bearish read.

Key Financial Metrics

Direction
selling
Total Value
$3.8M
Insiders
2

Actionable Insight

The insider sales are routine in size and carry no material signal. Monitor upcoming quarterly results for any fundamental changes, but this cluster alone does not warrant a trading action.

Key Facts

  • Two EVPs sold a combined $3.79M in open-market sales (May 19–26, 2026).
  • Sales represent ~0.03% of Exelixis's $12.6B market cap — trivial in size.
  • Both sellers are C-suite executives (EVP Commercial, EVP R&D), but insider sales clusters are not predictive per academic literature.
  • No 10b5-1 plan disclosure; however, the small dollar amount relative to market cap makes this routine.
  • Historical calibration shows negative net alpha at T+20 for this filing segment, and score-6/7/8 observed win rates are below 50%.

Financial Impact

Total insider sales of $3.79M represent ~0.03% of market cap — immaterial.

insider holdings

Risk Factors

  • Insider sales could accelerate if management anticipates near-term headwinds, though the current dollar amount is too small to suggest this.
  • No cross-filing context (earnings, agreements, offerings) was provided to amplify the signal.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
58% bullish (26 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-EXEL-1780007140867
10 reports for EXEL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for EXEL — sortable, filterable
Type Now
Jun 3, 2026
6d ago
Insider Cluster
NEUTRAL ★ 2/10
$52.39 $52.69▲ +0.57%▲ +3.17%$51.74 (−1.24%)
May 29, 2026
11d ago
8-K
NEUTRAL ★ 3/10
$50.20 $48.49▼ −3.41%▼ −3.55%$51.74 (+3.07%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.28▼ −0.08%▼ −0.35%$51.74 (+2.83%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.28▼ −0.08%▼ −0.35%$51.74 (+2.83%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.20▼ −0.24%▼ −0.50%$51.74 (+2.83%)
May 22, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$49.94 $49.82▼ −0.24%▼ −0.25%$51.74 (+3.61%)
May 19, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$49.89 $49.49▼ −0.80%▼ −1.00%$51.74 (+3.71%)
May 7, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$46.10 $48.15▲ +4.45%▲ +3.62%$51.74 (+12.24%)
Apr 17, 2026
7w ago
DEFA14A
NEUTRAL ★ 3/10
$43.59 $45.88▲ +5.25%▲ +5.91%$51.74 (+18.70%)
Feb 28, 2026
14w ago
Institutional Cluster
BULLISH ★ 7/10
$40.98 $40.58▼ −0.98%▼ −0.06%$51.74 (+26.26%)
Showing 10 of 10

US Market Status

Market Closed — Opens in 6h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access